Bounc­ing back, Med­i­ci­No­va makes big gains af­ter tout­ing triglyc­eride da­ta from a tiny study

Shares of Med­i­ci­No­va rock­et­ed up more than 30% this morn­ing af­ter the biotech $MNOV tout­ed the ear­ly end of a small Phase IIa NASH …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.